How Genomics Research Could Change How Multiple Sclerosis Is Treated

1 min read

Multiple sclerosis (MS) affects more than 1 million people in the U.S. But advances in treating the disease continue to be made, especially with new tools for genomic research into the underlying issues that lead to MS. In this video recorded on March 11, 2021, Jason Hall, multimedia specialist with The Motley Fool and the host of Discovery Now, talks with 10x Genomics (NASDAQ: TXG) CEO and co-founder Serge Saxonov about how genomics research could change how MS is treated.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

Could Aurora Cannabis Be a Millionaire-Maker Stock?

Next Story

3 Great Reasons to Take Social Security Benefits at 62

Latest from Blog